Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RANOLAZINE
- Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
- The Safety of Paxlovid in Hemodialysis Patients With Covid-19
- Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
- Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
- A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency
- Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation
- CiPA Phase 1 ECG Biomarker Validation Study
- Targeting Right Ventricle in Pulmonary Hypertension Gilead
- A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects
- Ranolazine a Potential New Therapeutic Application
- Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics
- Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
- Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
- Ranolazine Among Unrevascularized Chronic Stable Angina Patients
- Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
- Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
- Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
- Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
- Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
- Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
- A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
- Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
- Ranolazine and Microvascular Angina by PET in the Emergency Department
- Study to Reduce Symptoms of Premature Beats With Ranolazine
- A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
- Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
- 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
- Effects of Ranolazine and Exercise on Daily Physical Activity Trial
- 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
- The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
- Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Targeting the Right Ventricle in Pulmonary Hypertension
- Impact of Ranolazine on Coronary Microcirculatory Resistance
- Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
- Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
- Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
- Ranolazine Cardioprotection in PCI
- LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
- Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
- Ranolazine for the Treatment of Chest Pain in HCM Patients
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
- A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
- Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
- Efficacy Study of Sodium Channel Blocker in LQT3 Patients
- Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
- Safety of Amiodarone and Ranolazine Together in Patients With Angina
- A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
- Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion
- Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
- The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- Ranolazine for Improving Symptoms of Palpitations
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
- Ranolazine Loading to Prevent PCI-induced Myocardial Injury
- Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
- The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
- Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
- Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
- Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion
- Ranolazine in Ischemic Cardiomyopathy
- Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
- A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
- Ranolazine, Ethnicity and the Metabolic Syndrome
- Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
- Ranolazine Implantable Cardioverter-Defibrillator Trial
- Ranolazine and Pulmonary Hypertension
- Ranolazine in Diastolic Heart Failure
- Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy
- Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
- Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
- Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy
- Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
- An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
- Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
- Microvascular Coronary Disease In Women: Impact Of Ranolazine
- Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
- Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine
Clinical trials list
click for details